BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pillai R, LeBoeuf SE, Hao Y, et al. (2024) Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in mutant lung cancer. Science Advances. 10: eadm9859 |
| Tendler S, Dunphy MP, Agee M, et al. (2024) First-in-human imaging with [Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate. Medrxiv : the Preprint Server For Health Sciences |
| Zavitsanou AM, Pillai R, Hao Y, et al. (2023) KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance. Cell Reports. 42: 113295 |
| Pillai R, LeBoeuf SE, Hao Y, et al. (2023) Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in mutant lung cancer. Biorxiv : the Preprint Server For Biology |
| Rudin CM, Balli D, Lai WV, et al. (2023) Clinical benefit from immunotherapy in patients with small cell lung cancer is associated with tumor capacity for antigen presentation. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer |
| Deng J, Peng DH, Fenyo D, et al. (2023) metabolomics identifies CD38 as an emergent vulnerability in -mutant lung cancer. Biorxiv : the Preprint Server For Biology |
| Pan Y, Han H, Hu H, et al. (2022) KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition. Cancer Cell |
| Offin M, Sauter JL, Tischfield SE, et al. (2022) Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library. Genome Medicine. 14: 127 |
| Quintanal-Villalonga Á, Chan JM, Masilionis I, et al. (2022) Protocol to dissociate, process, and analyze the human lung tissue using single-cell RNA-seq. Star Protocols. 3: 101776 |
| Chemi F, Pearce SP, Clipson A, et al. (2022) cfDNA methylome profiling for detection and subtyping of small cell lung cancers. Nature Cancer |